论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
感染 Omicron 并接受 Paxlovid 治疗的高危 COVID-19 患者的病毒脱落时间缩短:来自中国的真实世界研究
Authors Yang W, Peng Y, Wang C , Cai H, Zhang L, Xu J, Wang Y, Wang M, Zhao M, Yu K
Received 24 October 2023
Accepted for publication 23 March 2024
Published 29 March 2024 Volume 2024:17 Pages 1267—1279
DOI https://doi.org/10.2147/IDR.S443574
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Sandip Patil
Introduction: The purpose of this study was to compare the viral shedding time in patients infected with the Omicron variant during Paxlovid therapy and conventional therapy and to analyze the effects of Paxlovid on patients infected with COVID-19.
Methods: In this study, the demographic and clinical characteristics and laboratory data of 3159 patients infected with the SARS-CoV-2 Omicron variant treated at Jilin Province People’s Hospital were collected and analyzed. A total of 362 patients received Paxlovid therapy, and 2797 patients received conventional therapy. After propensity score matching (PSM), 1086 patients were obtained.
Results: The difference in platelet (PLT) count between the two groups was statistically significant but within the normal range (P < 0.05). CT value revealed that the nucleic acid test results became negative more quickly in the Paxlovid therapy group. Analysis of the Paxlovid therapy group showed that IgG and IgM levels were increased after Paxlovid therapy administration.
Conclusion: The CT value of the Paxlovid therapy group became negative more quickly. This finding suggests that Paxlovid treatment after early diagnosis of the Omicron variant may achieve good therapeutic efficacy.
Keywords: Paxlovid, Omicron variant, a retrospective study, N-CT